Charlotte Ermine

Dr. Charlotte Ermine


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in International Journal of Stroke
Verified
Journal Article
Closed access
PDF file
CECharlotte Ermine
Charlotte Ermine
ABAndrew Bivard
Andrew Bivard
MPMark W Parsons
Mark W Parsons
JBJean-Claude Baron
Jean-Claude Baron
The discovery that brain tissue could potentially be salvaged from ischaemia due to stroke, has led to major advances in the development of therapies for ischemic stroke. In this review, we detail the advances in the understanding of this area termed the ischaemic penumbra, from its discovery to the evolution of imaging techniques, and finally some of the treatments developed. Evolving from animal studies from the 70s and 80s and translated to clinical practice, the field of ischemic reperfusion therapy has largely been guided by an array of imaging techniques developed to positively identify the ischemic penumbra, including positron emission tomography, computed tomography and magnetic resonance imaging. More recently, numerous penumbral identification imaging studies have allowed for a better understanding of the progression of the ischaemic core at the expense of the penumbra, and identification of patients than can benefit from reperfusion therapies in the acute phase. Importantly, 40 years of critical imaging research on the ischaemic penumbra have allowed for considerable extension of the treatment time window and better patient selection for reperfusion therapy. The translation of the penumbra concept into routine clinical practice has shown that “tissue is at least as important as time.”

1 April 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
CGCarlos W. Gantner
Carlos W. Gantner
ILIsabelle R. de Luzy
Isabelle R. de Luzy
JKJessica A. Kauhausen
Jessica A. Kauhausen
NMNiamh Moriarty
Niamh Moriarty
JNJonathan C. Niclis
Jonathan C. Niclis
CPClare L. Parish
Clare L. Parish

22 October 2019 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ILIsabelle R. de Luzy
Isabelle R. de Luzy
JNJonathan C. Niclis
Jonathan C. Niclis
CGCarlos W. Gantner
Carlos W. Gantner
JKJessica A. Kauhausen
Jessica A. Kauhausen
CHCameron P.J. Hunt
Cameron P.J. Hunt
CPClare L. Parish
Clare L. Parish
Human pluripotent stem cells (hPSCs) are a promising resource for the replacement of degenerated ventral midbrain dopaminergic (vmDA) neurons in Parkinson's disease. Despite recent advances in protocols for thein vitrogeneration of vmDA neurons, the asynchronous and heterogeneous nature of the differentiations results in transplants of surprisingly low vmDA neuron purity. As the field advances toward the clinic, it will be optimal, if not essential, to remove poorly specified and potentially proliferative cells from donor preparations to ensure safety and predictable efficacy. Here, we use two novel hPSC knock-in reporter lines expressing GFP under the LMX1A and PITX3 promoters, to selectively isolate vm progenitors and DA precursors, respectively. For each cell line, unsorted, GFP+, and GFP−cells were transplanted into male or female Parkinsonian rodents. Only rats receiving unsorted cells, LMX1A-eGFP+, or PITX3-eGFP−cell grafts showed improved motor function over 6 months. Postmortem analysis revealed small grafts from PITX3-eGFP+cells, suggesting that these DA precursors were not compatible with cell survival and integration. In contrast, LMX1A-eGFP+grafts were highly enriched for vmDA neurons, and importantly excluded expansive proliferative populations and serotonergic neurons. These LMX1A-eGFP+progenitor grafts accelerated behavioral recovery and innervated developmentally appropriate forebrain targets, whereas LMX1A-eGFP−cell grafts failed to restore motor deficits, supported by increased fiber growth into nondopaminergic target nuclei. This is the first study to use an hPSC-derived reporter line to purify vm progenitors, resulting in improved safety, predictability of the graft composition, and enhanced motor function.SIGNIFICANCE STATEMENTClinical trials have shown functional integration of transplanted fetal-derived dopamine progenitors in Parkinson's disease. Human pluripotent stem cell (hPSC)-derived midbrain progenitors are now being tested as an alternative cell source; however, despite current differentiation protocols generating >80% correctly specified cells for implantation, resultant grafts contain a small fraction of dopamine neurons. Cell-sorting approaches, to select for correctly patterned cells before implantation, are being explored yet have been suboptimal to date. This study provides the first evidence of using 2 hPSC reporter lines (LMX1A-GFP and PITX3-GFP) to isolate correctly specified cells for transplantation. We show LMX1A-GFP+, but not PITX3-GFP+, cell grafts are more predictable, with smaller grafts, enriched in dopamine neurons, showing appropriate integration and accelerated functional recovery in Parkinsonian rats.

24 February 2018 in Hippocampus
Verified
Journal Article
Open access
PDF file
CECharlotte Ermine
Charlotte Ermine
JWJordan L Wright
Jordan L Wright
SFStefano Frausin
Stefano Frausin
JKJessica A. Kauhausen
Jessica A. Kauhausen
CPClare L. Parish
Clare L. Parish
LTLachlan H. Thompson
Lachlan H. Thompson
Key pathological features of Parkinson's Disease (PD) include the progressive degeneration of midbrain dopaminergic (DA) neurons and hindbrain noradrenergic (NA) neurons. The loss of DA neurons has been extensively studied and is the main cause of motor dysfunction. Importantly, however, there are a range of ‘non‐movement’ related features of PD including cognitive dysfunction, sleep disturbances and mood disorders. The origins for these non‐motor symptoms are less clear, but a possible substrate for cognitive decline may be reduced adult‐hippocampal neurogenesis, which is reported to be impaired in PD. The mechanisms underlying reduced neurogenesis in PD are not well established. Here we tested the hypothesis that NA and DA depletion, as occurs in PD, impairs hippocampal neurogenesis. We used 6‐hydroxydopamine or the immunotoxin dopamine‐β‐hydroxylase‐saporin to selectively lesion DA or NA neurons, respectively, in adult Sprague Dawley rats and assessed hippocampal neurogenesis through phenotyping of cells birth‐dated using 5‐bromo‐2′‐deoxyuridine. The results showed no difference in proliferation or differentiation of newborn cells in the subgranular zone of the dentate gyrus after NA or DA lesions. This suggests that impairment of hippocampal neurogenesis in PD likely results from mechanisms independent of, or in addition to degeneration of DA and NA neurons.

5 July 2016 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
JWJordan L Wright
Jordan L Wright
CECharlotte Ermine
Charlotte Ermine
JJJesper R. Jørgensen
Jesper R. Jørgensen
CPClare L. Parish
Clare L. Parish
LTLachlan H. Thompson
Lachlan H. Thompson
A number of studies have shown that damage to brain structures adjacent to neurogenic regions can result in migration of new neurons from neurogenic zones into the damaged tissue. The number of differentiated neurons that survive is low, however, and this has lead to the idea that the introduction of extrinsic signalling factors, particularly neurotrophic proteins, may augment the neurogenic response to a level that would be therapeutically relevant. Here we report on the impact of the relatively newly described neurotrophic factor, Meteorin, when over-expressed in the striatum following excitotoxic injury. Birth-dating studies using bromo-deoxy-uridine (BrdU) showed that Meteorin did not enhance injury-induced striatal neurogenesis but significantly increased the proportion of new cells with astroglial and oligodendroglial features. As a basis for comparison we found under the same conditions, glial derived neurotrophic factor significantly enhanced neurogenesis but did not effect gliogenesis. The results highlight the specificity of action of different neurotrophic factors in modulating the proliferative response to injury. Meteorin may be an interesting candidate in pathological settings involving damage to white matter, for example after stroke or neonatal brain injury.

14 October 2021 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
CECharlotte Ermine
Charlotte Ermine
JNJess Nithianantharajah
Jess Nithianantharajah
KOKatrina O’brien
Katrina O’brien
JKJessica A. Kauhausen
Jessica A. Kauhausen
SFStefano Frausin
Stefano Frausin
LTLachlan H. Thompson
Lachlan H. Thompson